Price (delayed)
$0.5188
Market cap
$52.28M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.23
Enterprise value
$52.91M
FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics. The Company applies its pioneering expertise in hypoxia-inducible factor (HIF) and connective tissue
There are no recent dividends present for FGEN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.